Substitution of Factor XIII: A Therapeutic Approach to Ulcerative Colitis
- 1 January 1991
- journal article
- case report
- Published by S. Karger AG in Pathophysiology of Haemostasis and Thrombosis
- Vol. 21 (1) , 5-9
- https://doi.org/10.1159/000216195
Abstract
Three patients with ulcerative colitis in the active stage demonstrated reduced levels of F XIII activity and F XIII subunit A (61 and 80.3%, respectively). Because of the lack of clinical improvement during conservative therapy, the patients were treated additionally with F XIII concentrate (Fibrogammin HS®, Behring, FRG) for 10 days. The substitution resulted in an increase in F XIII activity (144.3%) and F XIII subunit A (238%) as well as in a marked improvement in symptoms.Keywords
This publication has 0 references indexed in Scilit: